Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression.
about
Targeting cancer-related inflammation: Chinese herbal medicine inhibits epithelial-to-mesenchymal transition in pancreatic cancerMyeloid-derived suppressor cells: linking inflammation and cancerProinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cellsCytokine-Induced Modulation of Colorectal CancerThe Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor BedsMyeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor MicroenvironmentTherapeutic cancer vaccines: past, present, and futureHampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancerTumor microenvironment: regulatory cells and immunosuppressive cytokinesInflammatory networks and immune surveillance of pancreatic carcinomaThe Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer ProgressionPhenotype, development, and biological function of myeloid-derived suppressor cellsMyeloid-derived suppressor cells as regulators of the immune systemStat3 mediates myeloid cell-dependent tumor angiogenesis in miceInflammation and skeletal metastasisIdentification of myeloid derived suppressor cells in dogs with naturally occurring cancerLife history trade-offs in cancer evolutionMicroenvironmental regulation of metastasisLeukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapyMyeloid-derived suppressor cells: the dark knight or the joker in viral infections?Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer.Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells.Blockade of Fas signaling in breast cancer cells suppresses tumor growth and metastasis via disruption of Fas signaling-initiated cancer-related inflammation.Potent induction of B- and T-cell immunity against human carcinoembryonic antigen-expressing tumors in human carcinoembryonic antigen transgenic mice mediated by direct lentivector injection.Interleukin-6 induces Gr-1+CD11b+ myeloid cells to suppress CD8+ T cell-mediated liver injury in miceAccumulation of myeloid-derived suppressor cells (MDSCs) induced by low levels of IL-6 correlates with poor prognosis in bladder cancerCluster intradermal DNA vaccination rapidly induces E7-specific CD8+ T-cell immune responses leading to therapeutic antitumor effects.Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells.Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and functionTumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressive.TLR2-mediated expansion of MDSCs is dependent on the source of tumor exosomes.Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver.Helicobacter pylori and gastric cancer: factors that modulate disease risk.Importance of interleukin-1 and interleukin-1 receptor antagonist in short-term glucose sensor function in vivo.Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patientsIDO is a nodal pathogenic driver of lung cancer and metastasis development.Role of innate immunity in Helicobacter pylori-induced gastric malignancy.HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cellsIdentification of myeloid derived suppressor cells in the peripheral blood of tumor bearing dogs.IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus.
P2860
Q21132666-2CB40020-61A8-452A-8750-64D63B0BF24AQ24641811-3C86062C-7B4E-4D95-B63A-029F64F78D89Q24658240-01A27869-545C-419C-A47D-5A0C8F965267Q26752374-8572E2F2-0DD8-4C30-A826-8A65884BB286Q26799120-B28E225B-282C-4D4A-B740-5023901CE4AFQ26799126-189285D0-E620-4C24-AC12-DB0D12507D38Q26863283-9C55A380-F664-47E9-B732-82D2DC4B41DBQ26863418-7411CC4D-2355-4539-8725-11345F422151Q27007772-341FDE6B-4649-430B-A456-940813B12F2DQ27013983-0AB8660D-0DE8-4DCD-B027-A41BEA1CBBB0Q28076760-3693D6F1-2713-4694-93E2-BD547991DF3CQ28079046-8C758D2F-BE23-4D05-9EA0-FF035D3211E0Q28131637-67F4C53F-D307-46A6-AA27-7422DE41E778Q28385532-90819484-54F7-4CD5-A99B-338FD210BE97Q28396089-59F1D4D4-8B3B-48BD-AFDB-671765892F59Q28481476-DE49B32F-D98E-483D-871F-44CCF9794E28Q28657962-B4143912-043E-4692-B379-8558ADF7693FQ29547660-0783D09C-63AF-411A-8235-C3A2CBA2D53DQ29618033-4B63656C-BC69-485F-9C7E-49D54F142F47Q30411008-B0C002B6-8F22-4E37-B11A-8BABBD4F3E2BQ33514852-58C21947-7506-42C0-BD7E-ABFE26312145Q33567728-C81CD075-294B-4127-916A-DAB79DD9A943Q33676412-3410AADB-5838-4B20-B7BF-567AF18B4ADEQ33756770-EAD36572-CB86-4A26-AC4C-F757D97D57ACQ33843364-41241F30-C8DE-478D-9C16-85EC4168398FQ33888808-262B6313-1D9F-4A6B-A080-0F88BC7FCFC1Q33923717-EB58C8AB-B560-4461-96C4-68FC5252740BQ34078014-3880DFC7-D29B-4CE0-9060-BEED0C324235Q34087816-42503841-92AB-4869-AAF6-7333951CAE40Q34113544-E152DA09-1595-4CD9-A39F-9E7F18A0DFB5Q34162267-2D918CD7-BE35-4FF7-88E6-99A80D985BCBQ34163882-D1C64EF6-47DD-4DD5-BA15-1D88DA2C8290Q34189885-AAA19AB9-199C-4846-823C-9F8BA2256F15Q34209078-F256AF79-6147-4592-8DB8-2A1A340DBF89Q34250873-F7F68F4E-A41C-4BB4-98E0-13364AD077D9Q34289698-E23E209F-B5D1-4AC1-AF5C-6902C26260FBQ34343194-937D79DD-A79B-48E7-B41B-7AC77961D30EQ34353413-A97C1991-BD00-4E01-9CB0-940CDD6510EBQ34461732-2EB1940A-0B51-4271-A631-62E436F0ED42Q34483744-1B6CB410-DEC9-4769-85E4-94040E246A4C
P2860
Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Reduced inflammation in the tu ...... and limits tumor progression.
@ast
Reduced inflammation in the tu ...... and limits tumor progression.
@en
type
label
Reduced inflammation in the tu ...... and limits tumor progression.
@ast
Reduced inflammation in the tu ...... and limits tumor progression.
@en
prefLabel
Reduced inflammation in the tu ...... and limits tumor progression.
@ast
Reduced inflammation in the tu ...... and limits tumor progression.
@en
P2093
P2860
P1433
P1476
Reduced inflammation in the tu ...... and limits tumor progression.
@en
P2093
Jeff Leips
Linglin Yang
Pratima Sinha
Stephanie K Bunt
Suzanne Ostrand-Rosenberg
Virginia K Clements
P2860
P304
10019-10026
P356
10.1158/0008-5472.CAN-07-2354
P407
P577
2007-10-01T00:00:00Z